688358 祥生医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.2848.30910.07310.9218.272
总资产报酬率 ROA (%)2.9057.3009.0089.6487.269
投入资产回报率 ROIC (%)3.1277.9309.75410.6498.049

边际利润分析
销售毛利率 (%)61.00759.09858.95458.08459.284
营业利润率 (%)38.00129.12833.56133.52830.231
息税前利润/营业总收入 (%)37.81323.79624.72928.61922.826
净利润/营业总收入 (%)36.16126.73229.97830.27527.792

收益指标分析
经营活动净收益/利润总额(%)79.22188.91289.86285.94877.595
价值变动净收益/利润总额(%)0.4662.6664.0118.34910.965
营业外收支净额/利润总额(%)3.5041.325-0.289-0.018-0.001

偿债能力分析
流动比率 (X)10.2057.1778.4249.6927.104
速动比率 (X)9.1766.5177.6678.7106.059
资产负债率 (%)9.81213.25711.04710.07713.238
带息债务/全部投入资本 (%)3.1404.1043.3161.2641.766
股东权益/带息债务 (%)3,044.4692,310.7682,895.8047,725.4705,511.705
股东权益/负债合计 (%)919.189654.335805.215892.369655.383
利息保障倍数 (X)-24.115-4.158-2.831-5.836-3.083

营运能力分析
应收账款周转天数 (天)144.826144.960121.45092.287108.388
存货周转天数 (天)243.755258.178245.378295.449344.073